Newsletter | May 17, 2024

05.17.24 -- Let's Clean Up That Bioburden — The Aseptic Suite's Persistent Plague

SPONSOR

FOCUS ON FACILITIES DESIGN

Let's Clean Up That Bioburden — The Aseptic Suite’s Persistent Plague

After decades of helping to rescue biotech and pharma companies from environmental monitoring excursions, Herman and Erich Bozenhardt bring this discussion about specific problems you should avoid.

Steps For Proper Cleaning Validation

Examine the steps of cleaning validation for both low-volume and high-volume manufacturers and the important role these studies play.

FACILITIES DESIGN SOLUTIONS

Time And Cost Saving Advantage Of Modular Vs. Stick Built Cleanrooms - AES Clean Technology, Inc.

SPONSOR

Webinar: How to value automation with the Return on Invested Capital model

Join us on June 4th when we’ll discuss the ROIC Capital of an automated facility for a Biophorum Digital Plant Maturity Model level of 2.0, 2.5 and 3.0. We will break down assumptions for developing the model, applications, inputs, COGS, and outputs of the model and share how ROIC correlates with the overall digital maturity of your operation. Click to learn more.

FOCUS ON PROCESS ENGINEERING

When Does GMP Matter In Non-GMP Settings?

Would you ever need to follow GMP standards in workspaces where GMP is not required or possible? This article digs into why, when, and how to follow the principles of GMP.

The Role Of Early Characterization Studies In The Assessment Of Advanced Therapeutic Potency

Early product characterization can serve to uncover crucial information about an advanced therapeutic candidate, affording new insight into its CQAs and helping to shape better analytical assays.

Bacteria Media Optimization Using In Silico Strategies

Determining ideal media composition for a bacteria is critical because it fosters a satisfactory grow rate, allowing the bacteria to reach the required growth yield.

Developing Robust mRNA Processes In A cGMP Environment

Explore current and emerging technologies to optimize mRNA manufacturing, especially when considering commercial production and the validation of processes in a cGMP environment.

Microphysiological Systems: The Future Of Research And Drug Development

Discover how microphysiological systems are revolutionizing the life sciences, offering a more accurate and reliable approach to studying human physiology and developing promising new drugs.

Address Current Challenges In Gene Therapy Viral Vector Manufacturing

This article addresses key advancements at each step in the production of viral vectors from maximizing titer output at scale upstream to optimized formulation compositions at fill/finish.

Manufacturing Challenges With High Concentration Biologics

Explore key process operations, some of the challenges in manufacturing high-concentration biologics, and factors to consider for process optimization.

Risk Assessment As A Process Quality Assurance Tool

Discover how an effective approach to risk management can further ensure the delivery of a high-quality drug or medicine to the patient.

Secure And Industrialize Your CGT Process Towards cGMP Manufacturing

Learn the principles of commercialization readiness and guidance to address them in process development as well as the best time to implement automation and minimize commercialization risks.

Developability Assessment Of Three Therapeutic Antibodies

Review studies for three monoclonal antibody drug candidates utilizing a panel of small scale, fast, and predictive tests used to evaluate therapeutic antibodies’ developability.

What Do You Need To Know About Analyzing AAVs With Mass Photometry?

This analytical instrument, designed to analyze AAV samples, can precisely determine the empty/full capsid ratio in samples of any serotype in a cost-effective, simple to operate way.

Microcalorimetry For The Biophysical Characterization Of Macromolecules

What is microcalorimetry and how is it used? Learn about measuring enthalpy and heat capacity changes during reactions using differential scanning calorimetry (DSC) and isothermal titration calorimetry (ITC).

Apply Quality By Design Principles To Cell And Gene Therapy Release Testing

Review how to develop and use QC assays that can facilitate both product and process understanding and control.

High Yield Protein Production System For Suspension CHO Cells

Reduced the risk of contamination caused by repeated handling of the culture during transient protein production in suspension CHO cells

Accelerate Time To A Robust And Reliable Commercial Scale Process

This five-step platform approach to process characterization ensures the entire process is right first time and results in a highly consistent product to facilitate efficient BLA filing.

LNP Formulation For mRNA delivery

Microfluidic mixing is one of the most effective means to formulate LNPs for its scalability and reproducibility. Explore LNP formulation, polishing, sterile filtration of mRNA-LNPs, and more.

Prioritize Safety And Mitigate Risk In HPAPI Manufacturing

As highly potent active pharmaceutical ingredients become increasingly common across the industry, it is critical to work with partners who use a risk-based approach to ensure safety and quality.

Transferring From Microfluidics To A Turbulent Mixer

What solutions did the client featured in this case study find when they sought help in transferring their formulation process to a turbulent Impinged Jet Mixing (IJM)?

Scale Up Manufacturing With Engineering Biology

Could an “engineering biology” approach be the solution for biopharmaceutical leaders struggling to scale-up and meet the growing demand for advanced therapeutics?

Connect With Bioprocess Online: